Form 4: GRI Bio Director Receives Stock Grant
Insider Transaction (Form 4)
Roelof Rongen, a Director of GRI Bio, Inc., received 3,935 shares of common stock on November 4, 2026.
Summary
- Grant/award: acquired 3,935 Stock Option (Right to Buy) on November 4, 2026; holds 3,935 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Roelof Rongen — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-04 | Grant/award | Stock Option (Right to Buy) | 3,935 | — | — | 3,935 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-04 | Grant/award (3,935 shares) |
Keywords
insider transaction, Form 4, GRI, GRI Bio, Inc., neutral, Roelof Rongen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.